PMID: 374767Jun 15, 1979Paper

Risk of pneumococcal infections in renal transplant patients

JAMA : the Journal of the American Medical Association
C C Linnemann, M R First

Abstract

Because of the recent licensing of pneumococcal vaccine, the risk of pneumococcal infections on a renal transplant service was determined. The overall risk of infection was 7% (14 of 197 patients) over a six-year period, or 1% per year. In patients with functioning allografts, this represented a risk of 28 infections per 1,000 patient-years of follow-up. Clinically, the major presentations of pneumococcal infection were pneumonia in the patient who was rejecting his kidney and pneumococcemia of sudden onset that was often fatal. Five of the pneumococci isolated from bacteremic patients were typed; three of the isolates were types that are in the vaccine. The frequency and seriousness of pneumococcal infections in renal transplant patients suggest that pneumococcal vaccine should be given to these patients, probably before transplantation.

Citations

Feb 13, 2002·The Pediatric Infectious Disease Journal·Margaret Helen Burroughs
Feb 1, 1994·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·R W Steele
Apr 12, 2005·Der Internist·W V KernH H Hirsch
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G E SchutzeS L Kaplan
Feb 9, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D KumarA McGeer
Jan 16, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D KumarA Humar
Apr 16, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·V BelvisiC M Mastroianni
Aug 1, 1983·The American Journal of Medicine·S J WeisholtzR B Roberts
Nov 20, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Liset OlarteSheldon L Kaplan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
I-Shiow JanLi-Na Lee
Canadian Respiratory Journal : Journal of the Canadian Thoracic Society
T J MarrieCanadian Community-Acquired Pneumonia Investigators
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J R BlancoJ San Román
© 2021 Meta ULC. All rights reserved